Advertisement
U.S. Markets close in 13 mins

Faron Pharmaceuticals Oy (FARN.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
152.50-5.00 (-3.17%)
At close: 06:16PM GMT
Full screen
Loading interactive chart...
  • Clinical Trials Arena

    Faron Pharmaceuticals reports positive data from MDS trial

    The combination treatment was found to be well tolerated without demonstrating any dose-limiting toxicity.

  • GlobeNewswire

    Faron Founders and bexmarilimab Developers Selected as Finalists for the European Inventor Award 2024

    Dr. Markku Jalkanen and Dr. Sirpa Jalkanen, Faron’s co-founders, have been nominated as one of three finalists in the ‘SMEs’ category of prestigious European Patent Office AwardsNominated in recognition of research developing bexmarilimab, an investigational immunotherapy optimising clinical outcomes in cancer treatmentVoting now open for “Popular Prize” award ahead of ceremony on July 9 via dedicated link: Sirpa Jalkanen and Markku Jalkanen | Epo.org TURKU, Finland and BOSTON, May 16, 2024 (GLO